STOCKHOLM: Sweden’s public health agency said on Monday that it recommended the use of Pfizer-BioNTech’s, Comirnaty vaccine against COVID-19 for children aged 12-15 who choose opponent Modernas Spikevax.
The European Medicines Agency approved the use of Comirnaty in May, while Spikevax gave nods to children over 12 in July. “All in all, we see reason to choose the vaccine that we know most about and that is most well-proven when it comes to vaccinating children between the ages of 12 and 15,” says Anders Tegnell, department head and state epidemiologist at the National Board of Health. The agency said there was more data on Comirnaty’s use on children. “Therefore, Spikevax is not recommended for the youngest age group in Sweden,” the agency said in a statement. In September, the agency said children aged 12 and over would be offered a COVID vaccination from 11 October.